Growth rate, scrotal circumference, sperm characteristics, and sexual behavior of mixed-breed goat bucks fed three leguminous trees

Aim of study: To investigate the effect of feeding foliage of leguminous trees on growth rate, semen characteristics, and sexual behavior of bucks. Area of study: Northeastern Mexico (23°44' N, 99°8' W). Material and methods: Twenty-two young goat bucks were randomly allocated to one of four treatment groups: 33% alfalfa hay (dry matter basis), 33%; Acacia farnesiana; Leucaena leucocephala; or Prosopis laevigata foliage (n=4 for alfalfa; n=6 for the rest of groups). Main results: Average daily gain (ADG) did not differ between bucks fed alfalfa, A. farnesiana, or L. leucocephala (120 ± 26, 134 ± 37, and 103 ± 29 g/d, respectively), but ADG of bucks offered P. laevigata was the lowest (72 ± 8 g; p<0.05). Bucks fed alfalfa had the highest feed efficiency (6.59 ± 1.25 kg of feed consumed/kg of gain; p<0.05) and bucks offered leguminous trees had the lowest (average 9.85 ± 2.3). Bucks offered alfalfa, and A. farnesiana had increased (p<0.05) scrotal circumference (26.6 ± 0.4 and 25.8 ± 1.5 cm) than bucks fed L. leucocephala, or P. laevigata (24.3 ± 1.2 and 24.1 ± 2.0 cm). Mean ejaculate volume was two-fold higher in alfalfa-fed bucks than all other dietary treatments. Sexual behavior did not differ among bucks fed the different legumes. Research highlights: Foliage of both A. farnesiana and L. leucocephala could totally replace alfalfa hay for rearing growing goat bucks in confinement without affecting daily weight gain, most semen characteristics, and copulation ability. P. laevigata reduced body weight and reproductive function

The PDZ-adaptor protein syntenin-1 regulates HIV-1 entry

Syntenin-1 is a cytosolic adaptor protein involved in several cellular processes requiring polarization. Human immunodeficiency virus type 1 (HIV-1) attachment to target CD4(+) T-cells induces polarization of the viral receptor and coreceptor, CD4/CXCR4, and cellular structures toward the virus contact area, and triggers local actin polymerization and phosphatidylinositol 4,5-bisphosphate (PIP(2)) production, which are needed for successful HIV infection. We show that syntenin-1 is recruited to the plasma membrane during HIV-1 attachment and associates with CD4, the main HIV-1 receptor. Syntenin-1 overexpression inhibits HIV-1 production and HIV-mediated cell fusion, while syntenin depletion specifically increases HIV-1 entry. Down-regulation of syntenin-1 expression reduces F-actin polymerization in response to HIV-1. Moreover, HIV-induced PIP(2) accumulation is increased in syntenin-1–depleted cells. Once the virus has entered the target cell, syntenin-1 polarization toward the viral nucleocapsid is lost, suggesting a spatiotemporal regulatory role of syntenin-1 in actin remodeling, PIP(2) production, and the dynamics of HIV-1 entry

The Y chromosome of autochthonous Basque populations and the Bronze Age replacement

Here we report on the Y haplogroup and Y-STR diversity of the three autochthonous Basque populations of Alava (n=54), Guipuzcoa (n=30) and Vizcaya (n=61). The same samples genotyped for Y-chromosome SNPs were typed for 17 Y-STR loci (DYS19, DYS385a/b, DYS398I/II, DYS390, DYS391, DYS392, DYS393, DYS437, DYS438, DYS439, DYS448, DYS456, DYS458, DYS635, Y-GATA H4) using the AmpFlSTR Yfiler system. Six major haplogroups (R, I, E, J, G, and DE) were detected, being R-S116 (P312) haplogroup the most abundant at 75.0% in Alava, 86.7% in Guipuzcoa and 87.3% in Vizcaya. Age estimates for the R-S116 mutation in the Basque Country are 3975±303, 3680±345 and 4553±285years for Alava, Guipuzcoa and Vizcaya, respectively. Pairwise Rst genetic distances demonstrated close Y-chromosome affinities among the three autochthonous Basque populations and between them and the male population of Ireland and Gascony. In a MDS plot, the population of Ireland segregates within the Basque cluster and closest to the population of Guipuzcoa, which plots closer to Ireland than to any of the other Basque populations. Overall, the results support the notion that during the Bronze Age a dispersal of individuals carrying the R-S116 mutation reached the Basque Country replacing the Paleolithic/Neolithic Y chromosome of the region

Evolution of Angiogenic Factors in Pregnant Patients with Breast Cancer Treated with Chemotherapy

Factors angiogènics; Quimioteràpia; EmbaràsFactores angiogénicos; Quimioterapia; EmbarazoAngiogenic factors; Chemotherapy; PregnancyHigh prevalence of placental-derived complications, such as preeclampsia and intrauterine growth restriction, has been reported in women with breast cancer (BC) treated with chemotherapy during pregnancy (PBC-CHT). Aim: To ascertain whether PBC-CHT is associated with an imbalance of angiogenic factors, surrogate markers for placental insufficiency, that could explain perinatal outcomes. Methods: Prospective study between 2012 and 2016 in a single institution. Soluble fms-like tyrosine kinase (sFlt-1), placental growth factor (PlGF), and soluble endoglin (sEng) in maternal blood were assessed throughout pregnancy in 12 women with BC and 215 controls. Results: Cancer patients were treated with doxorubicin-based regimes and with taxanes. Ten PBC-CHT (83%) developed obstetrical complications. At the end of the third trimester, significantly higher levels of sFlt-1; sFlt-1/PGF ratio, and sEng levels were observed in BC women as compared to controls. Moreover; there was a significant correlation between plasma levels of sFlt-1 and the number of chemotherapy cycles administered. Besides, more chemotherapy cycles correlated with lower birthweight and head circumference at birth. Conclusions: Women with BC treated during pregnancy showed an antiangiogenic state compatible with placental insufficiency. Angiogenic factors could be useful in the clinical obstetric management of these patients; although further studies will be required to guide clinical decision-making.This study was funded by the Spanish Research Project in Health funded by ISCIII, the state plan for scientific and technical research and innovation 2015–2018, and European Regional Development Fund (ERDF), ref. PI15/02252. This study was also supported in part by RETICS ‘Maternal and Child Health and Development Network’ (SAMID Network), funded by the PN I + D + i 2008–2016 (Spain), ISCIII-Sub-Directorate General for Research Assessment and Promotion, and the European Regional Development Fund (ERDF), ref. RD12/0026 and RD16/0022. O.S. was supported by SAMID Network (RD12/0026/0016 and RD16/0022/0015) and S.M. was supported by “Paseico de la mama”

Effect of a Very-Low-Calorie Ketogenic Diet on Circulating Myokine Levels Compared with the Effect of Bariatric Surgery or a Low-Calorie Diet in Patients with Obesity

The preservation of muscle mass and muscle function after weight loss therapy is currently a considerable challenge in the fight against obesity. Muscle mass secretes proteins called myokines that have relevant functions in the regulation of metabolism and health. This study was aimed to evaluate whether a very low-calorie ketogenic (VLCK) diet may modulate myokine levels, in addition to changes in body composition, compared to a standard, balanced low-calorie (LC) diet or bariatric surgery in patients with obesity. Body composition, ketosis, insulin sensitivity and myokines were evaluated in 79 patients with overweight/obesity after a therapy to lose weight with a VLCK diet, a LC diet or bariatric surgery. The follow-up was 6 months. The weight loss therapies induced changes in myokine levels in association with changes in body composition and biochemical parameters. The effects on circulating myokine levels compared to those at baseline were stronger after the VLCK diet than LC diet or bariatric surgery. Differences reached statistical significance for IL-8, MMP2 and irisin. In conclusion, nutritional interventions or bariatric surgery to lose weight induces changes in circulating myokine levels, being this effect potentially most notable after following a VLCK dietThis work was supported by the PronoKal Group® and grants from the Fondo de Investigacion Sanitaria, PI17/01287 research projects and CIBERobn (CB06/03/0003, CB12/03/30007, CB12/03/30002, CB06/03/0018) from the Instituto de Salud Carlos III (ISCIII)-Subdireccion General de Evaluacion y Fomento de la Investigación; Fondo Europeo de Desarrollo Regional (FEDER) and the Health Department of the Government of Navarra (48/2009), Spain and Linea Especial “Nutrition, Obesity and Health” (University of Navarra LE/97). Ana B Crujeiras is funded by a research contract “Miguel Servet” (CP17/00088) from the ISCIII, co-financed by the European Regional Development Fund (FEDER)S

Extreme genetic divergence in the endemic fish Chirostoma humboldtianum: implications for its conservation

Chirostoma humboltianum is an endemic species widely distributed in isolated basins of Central México. However, habitat alteration had reduced the range of distribution and led to the local extinction of the species in some basins. During the Miocene these basins were connected, allowing dispersal and colonization of new hydrological systems. Later on, tectonic, volcanic and climatic events of the Plio-Pleistocene promoted continuous periods of isolation and reconnection allowing the species evolve through continuous cycles of expansion and contraction of its distribution. Therefore it is expected that these events have left signals in the geographical distribution and genetic diversity and divergence of existing populations. Although the analysis of genetic diversity and genetic structure in the population becomes an important factor for the conservation of a species, few studies have been made in this taxon. In this study we used a 341pb segment of the domain I of the hypervariable region of the mitochondrial control region to analyze the genetic diversity and their distribution in 20 individuals of each one of six lakes located in central México. The values of haplotypic (0 - 0.938) and nucleotide (0 - 0.0352) diversity suggested continuous periods of expansion and population contraction related with the formation of the lakes during the Pleistocene which is supported by the BSP and mismatch analysis, and recent anthropogenic factors. In addition, the large number of exclusive haplotypes (66%) and the highly significant genetic differentiation among populations suggests that each one of the population must be conserved because each one is an important component in the evolutionary legacy of the species

EVALUACIÓN DEL PERFIL DEL ESPECIALISTA EN TRANSPORTE SUSTENTABLE EN MÉXICO

El transporte desempeña un papel clave y estratégico para el desarrollo de las actividades económicas, culturales y sociales de cualquier comunidad, ciudad, país o región. Los servicios de transporte ya sean de bienes o personas, para que puedan ser considerados de calidad deben poseer características como son: Seguridad, accesibilidad, confiabilidad, confort y sustentabilidad. Esta última característica, recientemente ha sido reconocida por organismos internacionales (Organización de las Naciones Unidas, Organización para la Cooperación y el Desarrollo Económico y Banco interamericano de Desarrollo), como un factor importante cuando se busca medir la competitividad de una localidad, país o región. De acuerdo a Sánchez y Wilmsmeier (2005) existe una relación positiva entre proporcionar una adecuada infraestructura de transporte y el crecimiento económico de un lugar, ya que permite ventajas importantes como generación de empleos, uso eficiente de recursos naturales, ahorros en tiempos de viaje, reducción de costos y una mejor salud para los habitantes

Single nucleotide polymorphisms associated with susceptibility for development of colorectal cancer: Case-control study in a Basque population

Given the significant population diversity in genetic variation, we aimed to investigate whether single nucleotide polymorphisms (SNPs) previously identified in studies of colorectal cancer (CRC) susceptibility were also relevant to the population of the Basque Country (North of Spain). We genotyped 230 CRC cases and 230 healthy controls for 48 previously reported CRC-susceptibility SNPs. Only the rs6687758 in DUPS10 exhibited a statistically significant association with CRC risk based on the crude analysis. The rs6687758 AG genotype conferred about 2.13-fold increased risk for CRC compared to the AA genotype. Moreover, we found significant associations in cases between smoking status, physical activity, and the rs6687758 SNP. The results of a Genetic Risk Score (GRS) showed that the risk alleles were more frequent in cases than controls and the score was associated with CRC in crude analysis. In conclusion, we have confirmed a CRC susceptibility locus and the existence of associations between modifiable factors and the rs6687758 SNP; moreover, the GRS was associated with CRC. However, further experimental validations are needed to establish the role of this SNP, the function of the gene identified, as well as the contribution of the interaction between environmental factors and this locusto the risk of CRC.This work was supported by two projects (from the Department of Health and Consumer Affairs, Basque Government 2011111153; and Saiotek, Basque Government S-PE12UN058), by a pre-doctoral grant from the Basque Government (PRE_2016_2_0046), by the CIBERehd and by the U.S. Department of Agriculture-Agricultural Research Service (ARS), under agreement. 581950-4-003. Neither Basque Government nor U.S. Department of Agriculture-Agricultural Research Service (ARS) had a role in the design, analysis or writing of this article. CIBERehd is funded by the Instituto de Salud Carlos III

Use of eltrombopag for patients 65 years old or older with immune thrombocytopenia

Background Eltrombopag is useful for immune thrombocytopenia (ITP). However, results of clinical trials may not accurately mirror clinical practice reality. Here we evaluated eltrombopag for primary and secondary ITP in our ≥65‐year‐old population. Methods A total of 106 primary ITP patients (16 with newly diagnosed ITP, 16 with persistent ITP, and 74 with chronic ITP) and 39 secondary ITP patients (20 with ITP secondary to immune disorders, 7 with ITP secondary to infectious diseases, and 12 with ITP secondary to lymphoproliferative disorders [LPD]) were retrospectively evaluated. Results Median age of our cohort was 76 (interquartile range, IQR, 70‐81) years. 75.9% of patients yielded a platelet response including 66.2% complete responders. Median time to platelet response was 14 (IQR, 8‐21) days. Median time on response was 320 (IQR, 147‐526) days. Sixty‐three adverse events (AEs), mainly grade 1‐2, occurred. The most common were hepatobiliary laboratory abnormalities (HBLAs) and headaches. One transient ischemic attack in a newly diagnosed ITP and two self‐limited pulmonary embolisms in secondary ITP were the only thrombotic events observed. Conclusion Eltrombopag showed efficacy and safety in ITP patients aged ≥65 years with primary and secondary ITP. However, efficacy results in LPD‐ITP were poor. A relatively high number of deaths were observed